These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 32659618)

  • 1. Atypical clinical presentation of pathologically proven Parkinson's disease: The role of Parkinson's disease related metabolic pattern.
    Rus T; Tomše P; Jensterle L; Ležaić L; Stokin CL; Popović M; Tang CC; Eidelberg D; Pirtošek Z; Trošt M
    Parkinsonism Relat Disord; 2020 Sep; 78():1-3. PubMed ID: 32659618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The utility of susceptibility-weighted imaging for differentiating Parkinsonism-predominant multiple system atrophy from Parkinson's disease: correlation with 18F-flurodeoxyglucose positron-emission tomography.
    Yoon RG; Kim SJ; Kim HS; Choi CG; Kim JS; Oh J; Chung SJ; Lee CS
    Neurosci Lett; 2015 Jan; 584():296-301. PubMed ID: 25450142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent Advancement and Clinical Implications of 18FDG-PET in Parkinson's Disease, Atypical Parkinsonisms, and Other Movement Disorders.
    Peralta C; Biafore F; Depetris TS; Bastianello M
    Curr Neurol Neurosci Rep; 2019 Jun; 19(8):56. PubMed ID: 31256288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abnormal metabolic brain network associated with Parkinson's disease: replication on a new European sample.
    Tomše P; Jensterle L; Grmek M; Zaletel K; Pirtošek Z; Dhawan V; Peng S; Eidelberg D; Ma Y; Trošt M
    Neuroradiology; 2017 May; 59(5):507-515. PubMed ID: 28386687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parkinson's disease-related perfusion and glucose metabolic brain patterns identified with PCASL-MRI and FDG-PET imaging.
    Teune LK; Renken RJ; de Jong BM; Willemsen AT; van Osch MJ; Roerdink JB; Dierckx RA; Leenders KL
    Neuroimage Clin; 2014; 5():240-4. PubMed ID: 25068113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Divergent expression of regional metabolic topographies in Parkinson's disease and normal ageing.
    Moeller JR; Eidelberg D
    Brain; 1997 Dec; 120 ( Pt 12)():2197-206. PubMed ID: 9448575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The utility of FDG-PET in the differential diagnosis of Parkinsonism.
    Brajkovic L; Kostic V; Sobic-Saranovic D; Stefanova E; Jecmenica-Lukic M; Jesic A; Stojiljkovic M; Odalovic S; Gallivanone F; Castiglioni I; Radovic B; Trajkovic G; Artiko V
    Neurol Res; 2017 Aug; 39(8):675-684. PubMed ID: 28378615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of the progression of Parkinson's disease: a metabolic network approach.
    Eckert T; Tang C; Eidelberg D
    Lancet Neurol; 2007 Oct; 6(10):926-32. PubMed ID: 17884682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of image reconstruction algorithms on topographic characteristics, diagnostic performance and clinical correlation of metabolic brain networks in Parkinson's disease.
    Tomše P; Peng S; Pirtošek Z; Zaletel K; Dhawan V; Eidelberg D; Ma Y; Trošt M
    Phys Med; 2018 Aug; 52():104-112. PubMed ID: 30139598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Network degeneration in Parkinson's disease: multimodal imaging of nigro-striato-cortical dysfunction.
    Ruppert MC; Greuel A; Tahmasian M; Schwartz F; Stürmer S; Maier F; Hammes J; Tittgemeyer M; Timmermann L; van Eimeren T; Drzezga A; Eggers C
    Brain; 2020 Mar; 143(3):944-959. PubMed ID: 32057084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different metabolic patterns analysis of Parkinsonism on the 18F-FDG PET.
    Juh R; Kim J; Moon D; Choe B; Suh T
    Eur J Radiol; 2004 Sep; 51(3):223-33. PubMed ID: 15294329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic value of brain MRI and 18F-FDG PET in the differentiation of Parkinsonian-type multiple system atrophy from Parkinson's disease.
    Kwon KY; Choi CG; Kim JS; Lee MC; Chung SJ
    Eur J Neurol; 2008 Oct; 15(10):1043-9. PubMed ID: 18717730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fatigue in Parkinson's disease: The contribution of cerebral metabolic changes.
    Cho SS; Aminian K; Li C; Lang AE; Houle S; Strafella AP
    Hum Brain Mapp; 2017 Jan; 38(1):283-292. PubMed ID: 27571419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationships among the metabolic patterns that correlate with mnemonic, visuospatial, and mood symptoms in Parkinson's disease.
    Mentis MJ; McIntosh AR; Perrine K; Dhawan V; Berlin B; Feigin A; Edwards C; Mattis P; Eidelberg D
    Am J Psychiatry; 2002 May; 159(5):746-54. PubMed ID: 11986127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 18F-FDG PET study on the idiopathic Parkinson's disease from several parkinsonian-plus syndromes.
    Zhao P; Zhang B; Gao S
    Parkinsonism Relat Disord; 2012 Jan; 18 Suppl 1():S60-2. PubMed ID: 22166456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic imaging and plasticity.
    Ko JH; Strafella AP
    Handb Clin Neurol; 2022; 184():121-132. PubMed ID: 35034729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regional metabolic changes in parkinsonian patients with normal dopaminergic imaging.
    Eckert T; Feigin A; Lewis DE; Dhawan V; Frucht S; Eidelberg D
    Mov Disord; 2007 Jan; 22(2):167-73. PubMed ID: 17133454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of brain MRI and 18F-FDG PET in the differential diagnosis of multiple system atrophy from Parkinson's disease.
    Kwon KY; Choi CG; Kim JS; Lee MC; Chung SJ
    Mov Disord; 2007 Dec; 22(16):2352-8. PubMed ID: 17894342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of 18F-FDG-PET image reconstruction algorithms on the expression of characteristic metabolic brain network in Parkinson's disease.
    Tomše P; Jensterle L; Rep S; Grmek M; Zaletel K; Eidelberg D; Dhawan V; Ma Y; Trošt M
    Phys Med; 2017 Sep; 41():129-135. PubMed ID: 28188080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Networks mediating the clinical effects of pallidal brain stimulation for Parkinson's disease: a PET study of resting-state glucose metabolism.
    Fukuda M; Mentis MJ; Ma Y; Dhawan V; Antonini A; Lang AE; Lozano AM; Hammerstad J; Lyons K; Koller WC; Moeller JR; Eidelberg D
    Brain; 2001 Aug; 124(Pt 8):1601-9. PubMed ID: 11459751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.